Pharmacology · Other important antibacterial agents

Metronidazole & the Nitroimidazoles

Prodrugs activated only inside anaerobes and microaerophiles, where nitro radical anions shred DNA — bactericidal against obligate anaerobes and antiprotozoal, defined clinically by the alcohol reaction and neuropathy on prolonged use.

Quick revision

Metronidazole is a prodrug: anaerobic and microaerophilic organisms reduce its nitro group via ferredoxin-linked electron transport to radical anions that break DNA — which is why it kills obligate anaerobes and protozoa but leaves aerobes untouched.

  • Mechanism: the nitro group is reduced inside anaerobes and microaerophiles by ferredoxin-linked electron transport (pyruvate:ferredoxin oxidoreductase pathway) to cytotoxic nitro radical anions that cause DNA strand breakage and cell death. (1)
  • Bactericidal against susceptible organisms — the DNA damage kills rather than pauses the cell. (1)
  • Spectrum: obligate anaerobes including Bacteroides fragilis and Clostridioides difficile, plus the protozoa Giardia, Entamoeba histolytica and Trichomonas vaginalis. (1)
  • Also a component of combination regimens for Helicobacter pylori and a first-line agent for bacterial vaginosis. (1)
  • Aerobic bacteria cannot reduce the prodrug, so metronidazole has no useful activity against them — the mirror image of the aminoglycosides. (1)
  • Metallic taste and gastrointestinal upset are the characteristic nuisance effects; a disulfiram-like reaction with alcohol is the classic counselling point. (1)
  • Peripheral neuropathy with prolonged use, and rare encephalopathy or cerebellar toxicity, are the neurological limits of the drug. (1)
  • Metronidazole inhibits warfarin metabolism (CYP2C9) and potentiates its anticoagulant effect — monitor the INR. (1)
  • Tinidazole and secnidazole are longer-acting nitroimidazoles used mainly for trichomoniasis, giardiasis, amoebiasis and bacterial vaginosis. (4) (3)

Overview

Metronidazole is the prototype nitroimidazole, in clinical use since the 1960s and still a first-choice agent for anaerobic bacterial infection and several protozoal diseases. The class also includes tinidazole and secnidazole, longer-acting relatives used mainly for trichomoniasis, giardiasis, amoebiasis and bacterial vaginosis. (1) (3)

What makes the class conceptually elegant is selective activation. Metronidazole enters cells as an inert prodrug; only organisms with anaerobic, ferredoxin-linked electron transport — obligate anaerobes and microaerophiles — can reduce its nitro group to cytotoxic radical anions. Those radicals break DNA strands and kill the cell, so the drug is bactericidal precisely where it is activated and inert everywhere else, including in aerobic bacteria and, largely, in human cells. (1)

Clinically the drug is defined as much by its counselling points as by its spectrum: the metallic taste patients notice, the disulfiram-like reaction that makes alcohol abstinence part of the prescription, the peripheral neuropathy that limits prolonged courses, and the warfarin interaction that demands INR monitoring. None of these is exotic, and every one of them is examinable. (1)

Classification and drug examples

A small class, best learned as the prototype plus two long-acting relatives whose pharmacokinetics enable shorter regimens.

Prototype nitroimidazole

The workhorse for anaerobic bacterial infection and protozoal disease, available orally, intravenously and topically/vaginally. (1)

  • Metronidazole (Flagyl) · Oral/IV/topical/vaginal — First-line for anaerobic infection, trichomoniasis, giardiasis, amoebiasis and bacterial vaginosis, and a component of H. pylori combination regimens. (1)

Long-acting nitroimidazoles

Longer half-lives permit short or single-dose regimens, mainly for protozoal infection and bacterial vaginosis. (4) (3)

  • Tinidazole · Oral — Used for trichomoniasis, giardiasis, amoebiasis and bacterial vaginosis; shares the alcohol caution and is avoided in pregnancy. (3) (4)
  • Secnidazole · Oral — A newer single-dose nitroimidazole used for bacterial vaginosis and trichomoniasis. (4)

Mechanism of action

Nitroimidazoles are prodrugs. Inside anaerobic and microaerophilic organisms, ferredoxin-linked electron transport — fed by pyruvate:ferredoxin oxidoreductase — reduces the nitro group to cytotoxic nitro radical anions, which cause DNA strand breakage, destabilise the helix and kill the cell.

Molecular target
DNA, attacked by reduced nitro radical anions generated only in anaerobic/microaerophilic cells
Killing effect
bactericidal
Kill kinetics
concentration-dependent
  1. The prodrug diffuses into the cell

    Metronidazole enters bacterial and protozoal cells passively; at this point it is pharmacologically inert. (1)

  2. Anaerobic metabolism reduces the nitro group

    In anaerobes and microaerophiles, low-redox electron carriers — ferredoxin, reduced via pyruvate:ferredoxin oxidoreductase — donate electrons to the drug's nitro group. (1)

  3. Cytotoxic nitro radical anions form

    Reduction generates short-lived nitro radical anions, the active species. Aerobic organisms cannot sustain this reduction, which is the entire basis of the drug's selectivity. (1)

  4. DNA is broken and the cell dies

    The radicals attack DNA, causing strand breakage and loss of helical structure; the damage is lethal, making the drug bactericidal against susceptible organisms. (1)

  5. Consumption of drug maintains the gradient

    Intracellular reduction consumes metronidazole, maintaining the concentration gradient that draws more prodrug into the very cells that are destroying themselves with it. (1)

Spectrum of activity

One rule explains the whole spectrum: if the organism lives without oxygen, metronidazole can be activated inside it; if it needs oxygen, the drug stays inert.

Spectrum by subclass
SubclassGram-positiveGram-negativeAnaerobesAtypicalsNotable gaps
class-wideAnaerobic gram-positive organisms, notably Clostridioides difficile and other clostridiaObligate anaerobic gram-negative bacilli, notably Bacteroides fragilis, Fusobacterium and Prevotella speciesObligate anaerobes are the core bacterial spectrumProtozoa: Trichomonas vaginalis, Giardia, Entamoeba histolytica, Microaerophiles: Helicobacter pylori (within combination regimens)Aerobic and facultative bacteria growing aerobically, Fungi and viruses (1)

Major clinical uses

Read each row as drug → organism → indication. Therapy is always directed by local susceptibility data and the treating clinician.

DrugOrganismIndicationRoleNote
MetronidazoleObligate anaerobes including Bacteroides fragilisAnaerobic and mixed intra-abdominal, pelvic, dental and soft-tissue infection, usually alongside an agent covering aerobestargetedAerobic cover must come from a partner drug, since metronidazole contributes nothing against aerobes. (1)
MetronidazoleClostridioides difficileC. difficile infection where guideline-preferred oral agents are unavailable or unsuitablereserveGuidelines now generally prefer other oral agents first-line; metronidazole retains a role defined by current local guidance. (1)
MetronidazoleTrichomonas vaginalisTrichomoniasis, with concurrent treatment of sexual partnerstargetedPartner treatment and abstinence until both are treated are part of the regimen, because reinfection mimics failure. (4)
MetronidazoleGiardia and Entamoeba histolyticaGiardiasis and amoebiasis, including amoebic liver abscesstargetedFor invasive amoebiasis a luminal agent is added afterwards to clear intestinal cysts, since metronidazole alone does not reliably eradicate the luminal stage. (1)
MetronidazoleGardnerella-associated polymicrobial overgrowthBacterial vaginosis, oral or vaginaltargetedA first-line option in current guidelines. (4) (1)
MetronidazoleHelicobacter pyloriComponent of combination eradication regimensadjunctAlways within a multi-drug regimen chosen from current guidance; never as monotherapy. (1)
TinidazoleTrichomonas vaginalis, Giardia, Entamoeba histolyticaTrichomoniasis, giardiasis and amoebiasis where a longer-acting agent or shorter course is preferredtargetedShares the alcohol caution; avoided in pregnancy. (3) (4)
SecnidazoleBacterial vaginosis flora; Trichomonas vaginalisSingle-dose therapy for bacterial vaginosis and trichomoniasistargetedThe long half-life is what makes single-dose therapy feasible. (4)

Pharmacokinetics

DrugRouteAbsorptionCSF penetrationMetabolismEliminationHalf-lifeAdjust in
MetronidazoleOral/IV/topical/vaginalWell absorbed orally, with wide tissue distribution including abscess cavitiesGood — crosses into CSF, which supports its use in anaerobic CNS infectionHepaticMainly renal excretion of drug and metabolitesSee prescribing referenceSevere hepatic impairment; see prescribing reference (1)
TinidazoleOralWell absorbed orallySee prescribing referenceHepaticRenal and biliaryLonger than metronidazole, enabling short or single-dose regimensSee prescribing reference (3)
SecnidazoleOralWell absorbed as oral granulesNot clinically relevant to its indicationsHepaticSee prescribing referenceThe longest of the three, the basis of single-dose therapySee prescribing reference (4)
  • Metronidazole's excellent oral bioavailability means the oral route achieves systemic exposure comparable to intravenous dosing in patients who can absorb it — the IV form is for patients who cannot take or absorb oral drug, not a stronger version. (1)
  • Wide distribution — including CSF and abscess fluid — is part of why the drug works in anaerobic infections at anatomically awkward sites. (1)
  • This page gives no dose regimens by design. Doses depend on indication, organism, hepatic function, age and formulation, and belong in a prescribing reference used by the treating clinician.

Adverse effects

Common

  • Metallic taste: The signature nuisance effect, often accompanied by dry mouth; harmless but a common reason patients report or stop the drug. (1)
  • Gastrointestinal upset: Nausea, anorexia and abdominal discomfort are the most frequent adverse effects. (1)
  • Dark urine: A harmless discolouration attributable to metabolites, worth warning about so it is not mistaken for something sinister. (1)

Serious adverse effects

  • Disulfiram-like reaction with alcohol: Flushing, tachycardia, nausea and vomiting described when alcohol is taken during or shortly after treatment. Counsel abstinence from alcohol during therapy and for a period after the last dose, for metronidazole and tinidazole alike. (1) (3)
  • Peripheral neuropathy: Sensory neuropathy — numbness and paraesthesiae — associated with prolonged or cumulative use; may be slow to resolve. Keep courses as short as the indication allows and stop and review if neuropathic symptoms appear. (1)
  • Encephalopathy and cerebellar toxicity: Rare central neurotoxicity — ataxia, dysarthria, nystagmus, confusion, seizures — mostly with high-dose or prolonged therapy; characteristic imaging changes are described and usually reversible on stopping. Stop the drug and image if cerebellar or encephalopathic features develop on treatment. (1)

Drug-specific effects

  • Metronidazole: Clinically apparent liver injury is very rare despite decades of enormous use; the drug is regarded as a well-tolerated agent hepatically. (2)
  • Tinidazole: Shares the class profile — metallic taste, gastrointestinal upset, the alcohol reaction — with liver injury likewise rare. (3)

Contraindications, precautions and interactions

Contraindications

  • Previous hypersensitivity to metronidazole or another nitroimidazole. (1)
  • Alcohol during treatment and for a period after the final dose, because of the disulfiram-like reaction; disulfiram itself is also avoided concurrently. (1)

Precautions

  • Pregnancy — an honest nuance rather than a single rule. Metronidazole crosses the placenta. Pooled human data have not shown a clear association with birth defects, and current STI guidelines permit treating symptomatic trichomoniasis at any stage of pregnancy; some product labelling and older guidance still advise avoiding first-trimester use for trichomoniasis. Tinidazole is avoided in pregnancy, particularly the first trimester. The prescribing decision belongs with the treating clinician and current local guidance. (4) (1)
  • Severe hepatic impairment, where reduced metabolism increases exposure. (1)
  • Pre-existing neurological disease or long anticipated treatment duration, given the neuropathy and rare CNS toxicity. (1)

Drug interactions

  • Warfarin: Metronidazole inhibits CYP2C9-mediated warfarin metabolism, potentiating anticoagulation and raising the INR; monitor closely and adjust per the treating clinician. (1)
  • Alcohol and disulfiram: Disulfiram-like reaction with alcohol; concurrent disulfiram is associated with psychotic reactions and is avoided. (1)
  • Lithium: Metronidazole can raise lithium levels; monitor where the combination is unavoidable. (1)

Resistance mechanisms

Reduced prodrug activation

Organisms that down-regulate the ferredoxin-linked reduction pathway generate fewer active radicals from the same drug exposure — resistance by refusing to arm the weapon. (1) (4)

Examples: Metronidazole-resistant Helicobacter pylori, Resistant Trichomonas vaginalis isolates

Combination regimens for H. pylori; alternative nitroimidazole regimens per guidelines for refractory trichomoniasis.

nim genes and other detoxifying pathways

Nitroimidazole-reductase (nim) genes described in Bacteroides can convert the drug along a non-lethal pathway, although clinically significant resistance in B. fragilis remains uncommon. (1)

Examples: Bacteroides species carrying nim genes

Susceptibility testing where anaerobic infection fails to respond; alternative anaerobic cover such as carbapenems or beta-lactam/beta-lactamase-inhibitor combinations.

Aerobic escape

Not resistance in the acquired sense, but the intrinsic limit of the class: any organism growing aerobically is untouchable, so mixed infections always need a partner agent for the aerobes. (1)

Examples: Facultative organisms growing aerobically in mixed infection

Pair metronidazole with an agent covering aerobic flora in mixed infection.

Metronidazole remains reliably active against most obligate anaerobes after six decades, an unusual record. Preserving it means using it where anaerobes or susceptible protozoa are actually the target — and remembering that apparent failure in trichomoniasis is more often an untreated partner than a resistant organism.

Comparison tables

Metronidazole, tinidazole and secnidazole at a glance

Shared mechanism, different durations. Regimen choice belongs to current guidelines and a prescribing reference.

DrugDuration profilePrincipal rolesPregnancy position
MetronidazoleStandard courses; oral, IV, topical and vaginal formsAnaerobic infection, trichomoniasis, giardiasis, amoebiasis, bacterial vaginosis, H. pylori regimensUsable for symptomatic trichomoniasis per current STI guidelines; some labelling still advises avoiding the first trimester for that indication (1) (4)
TinidazoleLonger half-life; short or single-dose regimensTrichomoniasis, giardiasis, amoebiasis, bacterial vaginosisAvoided, particularly in the first trimester (3) (4)
SecnidazoleLongest half-life; single-dose granulesBacterial vaginosis, trichomoniasisPer current labelling and guidelines (4)

High-yield exam pearls

  • Metronidazole is a prodrug that only anaerobes can switch on. (1) Reduction of the nitro group requires the low-redox ferredoxin-linked electron transport of anaerobic and microaerophilic organisms — pyruvate:ferredoxin oxidoreductase donates the electrons. Aerobes lack this machinery, so the drug stays inert inside them.
  • The kill mechanism is DNA strand breakage, not protein or wall inhibition. (1) The reduced nitro radical anion attacks DNA, causing strand breakage, loss of helical structure and cell death — which is why the effect is bactericidal.
  • One drug, two kingdoms: bacteria and protozoa. (1) Because activation depends on anaerobic metabolism rather than a bacteria-specific target, metronidazole kills anaerobic protozoa — Giardia, Entamoeba, Trichomonas — as readily as anaerobic bacteria.
  • Alcohol plus metronidazole is a classic exam and counselling pairing. (1) A disulfiram-like reaction — flushing, tachycardia, nausea, vomiting — is described with alcohol during and shortly after treatment, so patients are counselled to abstain from alcohol during therapy and for a period after the last dose.
  • Duration decides the neurotoxicity. (1) Peripheral neuropathy is associated with prolonged or cumulative use, and rare central effects — encephalopathy, cerebellar dysfunction with ataxia and dysarthria, seizures — are described mainly with high or extended dosing.
  • Warfarin plus metronidazole means a rising INR. (1) Metronidazole inhibits CYP2C9-mediated metabolism of warfarin, potentiating anticoagulation — a frequently tested and clinically real interaction.
  • For trichomoniasis, treat the partner too. (4) Guidelines recommend concurrent treatment of sexual partners, because reinfection from an untreated partner is a principal cause of apparent treatment failure.

Common exam traps

  • Trap: "Metronidazole is a broad-spectrum antibiotic." Actually: It is narrow in a very particular way: excellent against obligate anaerobes and anaerobic protozoa, and essentially inactive against aerobic bacteria, which cannot reduce the prodrug to its active radical. (1)
  • Trap: "The alcohol warning is folklore that can be skipped." Actually: The disulfiram-like reaction is a documented basis for counselling. Patients are advised to avoid alcohol during treatment and for a period after finishing, and the same caution applies to tinidazole. (1) (3)
  • Trap: "Metronidazole is neurologically inert." Actually: Peripheral neuropathy with prolonged use is well described, and rare encephalopathy and cerebellar toxicity — ataxia, dysarthria, nystagmus — can occur; new neurological symptoms on treatment warrant stopping and review. (1)
  • Trap: "Pregnancy guidance on metronidazole is a single simple rule." Actually: It is genuinely nuanced. Metronidazole crosses the placenta; meta-analyses have not shown a clear association with birth defects, and current STI guidelines permit treatment of symptomatic trichomoniasis at any stage of pregnancy, while some product labelling and older guidance still advise avoiding first-trimester use for trichomoniasis. Tinidazole is the one to avoid in pregnancy. (4) (1)
  • Trap: "All nitroimidazoles are interchangeable." Actually: They share the mechanism, but tinidazole and secnidazole have longer half-lives that allow short or single-dose regimens for protozoal infection and bacterial vaginosis, and their pregnancy and labelling positions differ from metronidazole's. (4) (3)

Self-test questions

Answers are hidden until you open them. These questions are written from this page's cited content and are for study only — they are not clinical guidance.

  1. What accounts for metronidazole's selective activity against anaerobic organisms?

    • It binds a ribosomal subunit found only in organisms that grow without oxygen
    • An oxygen-sensitive efflux pump concentrates it inside anaerobic cells
    • It arrives as an inert prodrug that only low-redox, ferredoxin-linked electron transport can reduce to an active form
    • Oxygen-dependent enzymes in aerobes destroy the molecule before it reaches its target
    Show answer

    Answer: It arrives as an inert prodrug that only low-redox, ferredoxin-linked electron transport can reduce to an active form

    The molecule crosses into cells doing nothing at all. Activation demands the anaerobic electron-transport machinery in which pyruvate:ferredoxin oxidoreductase supplies electrons to ferredoxin, and organisms that cannot run that chemistry leave the drug switched off. (1)

  2. Once the nitro group has been reduced inside a susceptible organism, how is the cell killed?

    • Peptidoglycan cross-links are prevented, so the wall cannot be completed
    • DNA gyrase is inhibited and supercoiling stops
    • The 50S ribosomal subunit is occupied and peptide elongation stalls
    • Radical anions attack DNA directly, breaking strands and destroying helical structure
    Show answer

    Answer: Radical anions attack DNA directly, breaking strands and destroying helical structure

    The active species is a short-lived radical, and the damage it does is chemical rather than enzymatic. Strands are severed and the helix loses its architecture, an injury lethal enough to make the drug bactericidal rather than merely growth-arresting. Continued reduction inside the cell also consumes drug, keeping a gradient that pulls in more of it. (1)

  3. A candidate describes metronidazole as a broad-spectrum antibiotic. Which statement corrects this?

    • It covers aerobic bacteria reliably but has no useful anaerobic activity
    • Its useful reach is limited to obligate anaerobes and anaerobic protozoa, with aerobic bacteria essentially untouched
    • It covers bacteria of every kind but no protozoa
    • It only becomes broad-spectrum when paired with a proton pump inhibitor
    Show answer

    Answer: Its useful reach is limited to obligate anaerobes and anaerobic protozoa, with aerobic bacteria essentially untouched

    The breadth here runs across kingdoms rather than across oxygen requirements. Obligate anaerobes such as Bacteroides fragilis and Clostridioides difficile fall within range, as do Giardia, Entamoeba histolytica and Trichomonas vaginalis, while anything growing aerobically does not — which is why mixed infection needs a partner agent to handle the aerobic component. (1)

  4. Which interaction is characteristically described for both metronidazole and tinidazole?

    • A disulfiram-like reaction on exposure to alcohol, with flushing, a fast pulse, nausea and vomiting
    • A pressor crisis precipitated by tyramine-rich foods
    • Loss of antibacterial activity in the presence of any alcohol-containing preparation
    • Serotonin syndrome when combined with an antihistamine
    Show answer

    Answer: A disulfiram-like reaction on exposure to alcohol, with flushing, a fast pulse, nausea and vomiting

    Alcohol taken during a course of either agent, or shortly after one finishes, has been reported to produce the flushing, tachycardia and vomiting pattern associated with disulfiram. It is a documented basis for the standard counselling point rather than a piece of folklore, and both nitroimidazoles carry it. (1) (3)

  5. Which adverse effect of metronidazole is most closely linked to prolonged or cumulative exposure?

    • Metallic taste
    • Dark urine
    • Peripheral sensory neuropathy
    • Nausea and abdominal discomfort
    Show answer

    Answer: Peripheral sensory neuropathy

    Numbness and paraesthesiae from sensory nerve involvement track with how much drug has been given over time and can be slow to settle, which is why course length is the practical limit on this agent. Taste disturbance, harmless discolouration of the urine by metabolites and gastrointestinal upset appear early and carry no such implication. Rare central toxicity — ataxia, dysarthria, nystagmus, confusion or seizures — also clusters around high or extended dosing. (1)

  6. By what mechanism does metronidazole potentiate warfarin?

    • It displaces warfarin from binding sites on plasma albumin
    • It inhibits CYP2C9, the route by which the more potent warfarin enantiomer is cleared
    • It induces CYP3A4 and increases formation of an active metabolite
    • It kills colonic aerobes and so reduces vitamin K absorption
    Show answer

    Answer: It inhibits CYP2C9, the route by which the more potent warfarin enantiomer is cleared

    Blocking that particular oxidative pathway leaves more active anticoagulant in circulation, so the INR climbs while the two drugs overlap and needs closer watching. Lithium concentrations can also rise on metronidazole, and concurrent disulfiram is avoided because psychotic reactions have been associated with the combination. (1)

  7. Which mechanism underlies nitroimidazole resistance described in Bacteroides species?

    • Production of extended-spectrum beta-lactamases
    • Methylation of 23S ribosomal RNA at the drug binding site
    • Acquisition of nim genes whose reductase diverts the drug down a route that never yields the lethal radical
    • Efflux through a porin channel shared with the aminoglycosides
    Show answer

    Answer: Acquisition of nim genes whose reductase diverts the drug down a route that never yields the lethal radical

    This is resistance by declining to arm the weapon rather than by destroying it: the organism processes the compound along a harmless pathway, so no DNA-damaging species is ever generated. Clinically significant resistance in B. fragilis nonetheless remains uncommon, and the same theme of reduced activation explains resistant Helicobacter pylori and refractory Trichomonas vaginalis isolates. (1)

Frequently asked questions

Why does metronidazole kill anaerobes but not aerobes?

Because it is a prodrug that only anaerobic metabolism can activate. Ferredoxin-linked electron transport, fed by pyruvate:ferredoxin oxidoreductase, reduces the nitro group to DNA-breaking radical anions — machinery aerobic bacteria simply do not run, so in them the drug stays inert. (1)

Is the alcohol warning with metronidazole real?

A disulfiram-like reaction — flushing, tachycardia, nausea, vomiting — is documented, and standard counselling is to avoid alcohol during treatment and for a period after the last dose. The same caution applies to tinidazole. (1) (3)

Can metronidazole be used in pregnancy?

The evidence is more reassuring than the drug's reputation: pooled human data have not shown a clear link with birth defects, and current STI guidelines permit treating symptomatic trichomoniasis at any stage of pregnancy. At the same time, some product labelling and older guidance still advise avoiding first-trimester use for trichomoniasis, and tinidazole is avoided in pregnancy. The decision sits with the treating clinician and current guidance. (4) (1)

Why does a course of metronidazole raise the INR in a patient on warfarin?

Metronidazole inhibits CYP2C9, the enzyme that clears the more potent warfarin enantiomer, so anticoagulation is potentiated. The INR needs closer monitoring for the duration of the interaction. (1)

What neurological problems can metronidazole cause?

Peripheral sensory neuropathy with prolonged or cumulative use is the main one, and it can be slow to resolve. Rarely, high-dose or extended therapy causes encephalopathy or cerebellar toxicity — ataxia, dysarthria, nystagmus — which usually reverses once the drug is stopped. New neurological symptoms on treatment are a reason to stop and review. (1)

Why treat the partner in trichomoniasis?

Because reinfection from an untreated sexual partner is a principal cause of apparent treatment failure. Guidelines recommend concurrent partner treatment and abstinence until both partners have completed therapy. (4)

References

  1. Metronidazole (StatPearls) StatPearls Publishing / NCBI Bookshelf, 2023
  2. Metronidazole (LiverTox) LiverTox, NIDDK / NCBI Bookshelf, 2020
  3. Tinidazole (LiverTox) LiverTox, NIDDK / NCBI Bookshelf, 2020
  4. Trichomoniasis — STI Treatment Guidelines, 2021 Centers for Disease Control and Prevention, 2021